RNA extracted from bacterial species comprises up to 98 % of ribosomal RNAs (rRNA), preventing the in-depth analysis of RNAs of interest, particularly in the context of Next Generation Sequencing
Vienna, Austria, January 10, 2020 /PRNewswire/ – The massive output of modern short-read next generation sequencing (NGS) platforms allows to multiplex hundreds of samples to be processed in one NGS
VIENNA, April 5, 2018 /PRNewswire/ — Identifying molecules that selectively modulate gene expression is highly desirable in drug development. However, standard RNA sequencing technologies and current metabolic RNA labeling methods
Press release Lexogen launches the SLAMseq product family for high throughput metabolic sequencing of RNA, developed in collaboration with the Institute of Molecular Biotechnology in Vienna, Austria. Dr. Stefan Ameres
Lexogen GmbH
Campus Vienna Biocenter 5
1030 Vienna, Austria
Telephone:
+43 (0) 1 345 1212
Sales support:
+43 (0) 1 345 1212-42
Technical support:
+43 (0) 1 345 1212-41
Working hours: 9:00 – 17:00 (CET)
Fax: +43 (0) 1 345 1212-99
Email: info@lexogen.com
Company number: FN 297318 h
VAT number: ATU63622048
Lexogen, Inc.
51 Autumn Pond Park
Greenland, NH 03840, US
Telephone:
+1-603-431-4300 ext.0
+1-877-Lexogen
(+1-877-539-6436) ext. 0
Sales inquiries:
Northeast and Great Lakes:
+1 312-978-6413
California:
+1 415-726-4318
Rest of the Country:
+1 615-968-3325
Lexogen Newsletter
Subscribe to our mailing list to be among the first to get updates from us!
Copyright © 2026 Lexogen GmbH. All rights reserved | Impressum | Privacy Policy | Terms and Conditions | Whistleblowing
Product Short Description
PRICE
Product Short Description
PRICE
Product Short Description
PRICE
